QUEST DIAGNOSTICS INCORPORATED Quest Diagnostics Incorporated Share Price
Equities
DGX
US74834L1008
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 138.8 USD | -1.37% |
|
-2.71% | +0.69% |
| 11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
| 11/06 | Quest Diagnostics Completes Acquisition of PathAI Diagnostics From PathAI | MT |
| Sales 2024 * | 9.45B 789B | Sales 2025 * | 9.76B 815B | Capitalization | 15.42B 1,288B |
|---|---|---|---|---|---|
| Net income 2024 * | 895M 74.74B | Net income 2025 * | 970M 81.01B | EV / Sales 2024 * | 2.06 x |
| Net Debt 2024 * | 4.04B 338B | Net Debt 2025 * | 3.58B 299B | EV / Sales 2025 * | 1.95 x |
| P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
16.3
x | Employees | 44,000 |
| Yield 2024 * |
2.11% | Yield 2025 * |
2.14% | Free-Float | 68.24% |
More Fundamentals
* Assessed data
More news
Latest transcript on Quest Diagnostics Incorporated
More recommendations
More press releases
More news
| 1 day | -1.37% | ||
| 1 week | -2.71% | ||
| Current month | -2.21% | ||
| 1 month | +0.30% | ||
| 3 months | +7.01% | ||
| 6 months | -0.42% | ||
| Current year | +0.69% |
1 week
138.16
143.19
1 month
137.34145.62
Current year
123.04145.62
1 year
119.59145.62
3 years
119.59174.16
5 years
73.02174.16
10 years
56.27174.16
| Managers | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 61 | 01/13/01 |
Sam Samad
DFI | Director of Finance/CFO | 54 | 11/22/11 |
Kristin Wallace
CMP | Compliance Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Denise Morrison
BRD | Director/Board Member | 70 | 18/19/18 |
Timothy Ring
BRD | Director/Board Member | 66 | 07/11/07 |
Gary Pfeiffer
BRD | Director/Board Member | 74 | 01/04/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 14.84% | 208 M€ | +12.39% | - | |
| 2.17% | 2 M€ | +9.20% | ||
| 2.05% | 7 M€ | +5.53% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/24/12 | 138.8 | -1.37% | 831,178 |
| 11/24/11 | 140.8 | -0.50% | 543,983 |
| 10/24/10 | 141.5 | -0.61% | 589,490 |
| 07/24/07 | 142.3 | -0.21% | 366,223 |
| 06/24/06 | 142.6 | -0.04% | 618,418 |
Delayed Quote Nyse, June 13, 2024 at 01:30 am IST
More quotes
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Calendar
08/07/2024
- Détachement de
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.8
USD
Average target price
147
USD
Spread / Average Target
+5.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.69% | 15.42B | |
| +25.91% | 89.26B | |
| -24.02% | 75.31B | |
| +5.42% | 27.41B | |
| +6.52% | 18.36B | |
| -13.61% | 16.55B | |
| +79.76% | 13.83B | |
| -25.09% | 12.64B | |
| +22.83% | 12.53B | |
| +3.29% | 12.75B |
- Stock Market
- Equities
- DGX Stock
